Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only

The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 2026.

Follow this news feed: